» Articles » PMID: 9199205

Identification of Serine 380 As the Major Site of Autophosphorylation of Xenopus Pp90rsk

Overview
Publisher Elsevier
Specialty Biochemistry
Date 1997 Jun 18
PMID 9199205
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Rsk is a 90-kDa protein kinase that is activated by phosphorylation by MAP kinase at the end of a well-established signaling cascade. Rsk has two conserved catalytic kinase domains. The amino terminal kinase domain is responsible for phosphorylation of exogenous substrates. The carboxyl terminal domain of rsk has a basal autophosphorylation activity which can be detected when recombinant protein is incubated with [gamma-32P]ATP. The manner in which rsk activity is controlled by site specific phosphorylation is largely unknown. We show that rsk can autophosphorylate through an intermolecular mechanism. Autophosphorylation occurs primarily on serine 380, in a highly conserved region of rsk between its two kinase domains. That site of autophosphorylation is similar to sites found in other serine/threonine kinases, which are also regulated by phosphorylation at that corresponding site. The carboxyl terminal kinase domain of rsk becomes a potential candidate kinase involved in phosphorylating and regulating the activity of those other kinases through their conserved domains.

Citing Articles

RSK Isoforms in Acute Myeloid Leukemia.

Youn M, Gomez J, Mark K, Sakamoto K Biomedicines. 2021; 9(7).

PMID: 34202904 PMC: 8301392. DOI: 10.3390/biomedicines9070726.


RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit.

Chae H, Dutta R, Tiu B, Hoff F, Accordi B, Serafin V Oncotarget. 2020; 11(25):2387-2403.

PMID: 32637030 PMC: 7321696. DOI: 10.18632/oncotarget.27630.


Role of p90RSK in Kidney and Other Diseases.

Lin L, White S, Hu K Int J Mol Sci. 2019; 20(4).

PMID: 30813401 PMC: 6412535. DOI: 10.3390/ijms20040972.


Involvement of RSK1 activation in malformin-enhanced cellular fibrinolytic activity.

Koizumi Y, Nagai K, Gao L, Koyota S, Yamaguchi T, Natsui M Sci Rep. 2018; 8(1):5472.

PMID: 29615689 PMC: 5882963. DOI: 10.1038/s41598-018-23745-0.


Polypharmacology-based ceritinib repurposing using integrated functional proteomics.

Kuenzi B, Remsing Rix L, Stewart P, Fang B, Kinose F, Bryant A Nat Chem Biol. 2017; 13(12):1222-1231.

PMID: 28991240 PMC: 5909815. DOI: 10.1038/nchembio.2489.